CEL-SCI Corporation vs ImmunOs Therapeutics AG

CEL-SCI Corporation logo

CEL-SCI Corporation

Dedicated to research and development directed at improving the treatment of cancer, autoimmune and infectious diseases

45 employees · est. 1983 · Vienna, United States

VS
ImmunOs Therapeutics AG logo

ImmunOs Therapeutics AG

Novel human immunomodulatory proteins for cancer and autoimmune diseases with a specific role in innate immunity

15 employees · est. 2014 · Schlieren, Switzerland

CEL-SCI Corporation is the older company (1983 vs 2014).

Side-by-Side Comparison

CEL-SCI Corporation ImmunOs Therapeutics AG
Founded
1983 older 2014
Headquarters
Vienna, United States Schlieren, Switzerland
Employees
45 15
Industry
Biotechnology, Health Care Biotechnology, Health Care, Pharmaceutical
Funding Stage
Post-IPO Equity Series B
Total Funding
$86.03M $88.60M
Funding Rounds
11 6
Taxonomy
Not tracked yet ImmunotherapyCancer TreatmentAutoimmune DiseasesInnate ImmunityImmunomodulatory ProteinsTumor Microenvironment Remodeling +9
Website
cel-sci.com immunostherapeutics.com
CEL-SCI Corporation logo

About CEL-SCI Corporation

Cel-Sci is a biotechnology company dedicated to researching and developing treatments for cancer, autoimmune, and infectious diseases. The company's flagship product, Multikine, aims to boost the patient's immune system to target tumors while it is still intact and before conventional therapies. In...

ImmunOs Therapeutics AG logo

About ImmunOs Therapeutics AG

ImmunOs Therapeutics AG is a Swiss-based biotechnology company founded in 2014. The company specializes in developing novel human immunomodulatory proteins for cancer and autoimmune diseases, focusing on the innate immune system. Their lead program, iosH2, has shown promise in activating anti-tumor...

Also comparing in this category

Comparing more than these two?

Get CEL-SCI Corporation, ImmunOs Therapeutics AG and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does CEL-SCI Corporation compare?

A PDF of CEL-SCI Corporation and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Frequently Asked Questions

CEL-SCI Corporation was founded in 1983, based in Vienna, United States, with 45 employees. Cel-Sci is a biotechnology company dedicated to researching and developing treatments for cancer, autoimmune, and infectious diseases. The company's flagship product, Multikine, aims to boost the pati. ImmunOs Therapeutics AG was founded in 2014, based in Schlieren, Switzerland, with 15 employees. ImmunOs Therapeutics AG is a Swiss-based biotechnology company founded in 2014. The company specializes in developing novel human immunomodulatory proteins for cancer and autoimmune diseases, focusing.
CEL-SCI Corporation has raised $86.03M and ImmunOs Therapeutics AG $88.60M. Latest stage: CEL-SCI Corporation Post-IPO Equity, ImmunOs Therapeutics AG Series B.
Both work in Biotechnology and Health Care.

Compare CEL-SCI Corporation with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at CEL-SCI Corporation on 12 Sep 2024, and ImmunOs Therapeutics AG on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes